Item 7.01 Regulation FD Disclosure.

aTyr Pharma, Inc. (the "Company") is participating at the Society for Laboratory Automation and Screening Digital International Conference and Exhibition (SLAS) to be held virtually from January 25-27, 2021. The Company will be presenting a poster presentation entitled, "A Mass Spectrometry Proteomics-Based Approach to Identify Target Receptors for Novel Extracellular tRNA Synthetase Fragments," via a prerecorded audio recording on the SLAS website. The press release announcing the poster presentation is attached as Exhibit 99.1. The poster presentation has been posted on the Company's website and is attached hereto as Exhibit 99.2.

The information under this Item 7.01, including Exhibits 99.1 and 99.2 hereto, is being furnished herewith and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



Exhibit No.                               Description

99.1              Press Release of aTyr Pharma, Inc. dated January 22, 2021

99.2              Poster Presentation titled "A Mass Spectrometry
                Proteomics-Based Approach to Identify Target Receptors for Novel
                Extracellular tRNA Synthetase Fragments."







                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses